RXi Pharmaceuticals this week announced that Nassim Usman has joined its scientific advisory board. Usman is currently CEO and a director of Catalyst Biosciences. Prior to joining Catalyst, he was an entrepreneur-in-residence at Morgenthaler Ventures.
Usman previously held several positions during his 13-year tenure at Sirna. Usman is currently a member of the scientific advisory board of Noxxon Pharma.
Thermo Fisher Scientific this week announced that Paul M. Meister, chairman of the board and former vice chairman of Fisher Scientific International, decided to retire from the company’s board of directors.
The company also announced that Meister has relinquished his position as chairman of the board.